financetom
Business
financetom
/
Business
/
Neurocrine Biosciences Insider Sold Shares Worth $7,803,688, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Neurocrine Biosciences Insider Sold Shares Worth $7,803,688, According to a Recent SEC Filing
Jul 11, 2025 2:29 PM

05:06 PM EDT, 07/11/2025 (MT Newswires) -- Jude Onyia, Chief Scientific Officer, on July 09, 2025, sold 59,819 shares in Neurocrine Biosciences ( NBIX ) for $7,803,688. Following the Form 4 filing with the SEC, Onyia has control over a total of 18,289 common shares of the company, with 18,289 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/914475/000091447525000151/xslF345X05/wk-form4_1752267655.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved